Polycystic Ovarian Syndrome Treatment
Treatment for polycystic ovary disease may include hormone therapy. Additional treatment for polycystic ovary disease may include medications that reduce hair growth, and infertility medications.
Specific treatment for polycystic ovary disease may include:
- Regular exercise
- Weight loss if you are overweight
- Medication to regulate menstrual periods:
- Medications for high blood sugar:
- Medications for excessive hair:
- Medications for infertility:
Polycystic Ovarian Syndrome Questions For Doctor
The following are some important questions to ask before and after the treatment of polycystic ovary disease.
Questions to ask before treatment:
- What are my treatment options?
- Is surgery an option for me?
- What are the risks associated with treatment?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Do I need to lose weight?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- What else can I do to reduce my risk for polycystic ovary disease complications?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Polycystic Ovarian Syndrome Specialist
Physicians from the following specialties evaluate and treat polycystic ovary disease:
Continue to Polycystic Ovarian Syndrome Home Care
- Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. J Obstet Gynaecol. 2004 Sep;24(6):613-21. 
- Scarpitta AM, Sinagra D. Polycystic ovary syndrome: an endocrine and metabolic disease. Gynecol Endocrinol. 2000 Oct;14(5):392-5. 
- Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am. 1999 Jun;28(2):247-63.